• Citer

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial.

par van der Burg, Maria;Griffin, Clare L;Guthrie, David;Lamont, Alan;Jayson, Gordon C;Kristensen, Gunnar;Mediola, César;Coens, Corneel;Qian, Wendi;Parmar, Mahesh K B;Swart, Anne Marie;MRC OV05, Pascal;EORTC 55955 investigators, ;Rustin,
Référence Lancet, 376, 9747, page (1155-1163)
Publication Publié, 2010-10

Article révisé par les pairs

• Détails
• Contenu

Titre:	Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial.
Auteur:	van der Burg, Maria; Griffin, Clare L; Guthrie, David; Lamont, Alan; Jayson, Gordon C; Kristensen, Gunnar; Mediola, César; Coens, Corneel; Qian, Wendi; Parmar, Mahesh K B; Swart, Anne Marie; MRC OV05, Pascal; EORTC 55955 investigators, ; Rustin,
Informations sur la publication:	Lancet, 376, 9747, page (1155-1163)
Statut de publication:	Publié, 2010-10
Sujet CREF:	Cancérologie
MeSH keywords:	Adult
	Aged
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	CA-125 Antigen -- blood
	Carcinoma -- diagnosis -- drug therapy -- immunology
	Drug Administration Schedule
	Early Detection of Cancer
	Europe
	Evidence-Based Medicine
	Female
	Follow-Up Studies
	Humans
	Kaplan-Meier Estimate
	Middle Aged
	Neoplasm Recurrence, Local -- diagnosis -- drug therapy -- immunology
	Ovarian Neoplasms -- diagnosis -- drug therapy -- immunology
	Platinum Compounds -- administration & dosage
	Quality of Life
	Questionnaires
	Russia
	South Africa
	Time Factors
	Treatment Outcome
	Tumor Markers, Biological -- blood
Note générale:	Comparative Study
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0140-6736
	info:doi/10.1016/S0140-6736(10)61268-8
	info:pii/S0140-6736(10)61268-8
	info:pmid/20888993